PROCEPT BioRobotics (PRCT) Competitors $39.54 +1.08 (+2.80%) As of 11:06 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PRCT vs. STVN, IRTC, BLCO, GKOS, TMDX, NVST, LIVN, SLNO, WRBY, and INSPShould you be buying PROCEPT BioRobotics stock or one of its competitors? The main competitors of PROCEPT BioRobotics include Stevanato Group (STVN), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), Envista (NVST), LivaNova (LIVN), Soleno Therapeutics (SLNO), Warby Parker (WRBY), and Inspire Medical Systems (INSP). These companies are all part of the "medical equipment" industry. PROCEPT BioRobotics vs. Its Competitors Stevanato Group iRhythm Technologies Bausch + Lomb Glaukos TransMedics Group Envista LivaNova Soleno Therapeutics Warby Parker Inspire Medical Systems PROCEPT BioRobotics (NASDAQ:PRCT) and Stevanato Group (NYSE:STVN) are both mid-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability. Is PRCT or STVN more profitable? Stevanato Group has a net margin of 11.73% compared to PROCEPT BioRobotics' net margin of -30.60%. Stevanato Group's return on equity of 10.34% beat PROCEPT BioRobotics' return on equity.Company Net Margins Return on Equity Return on Assets PROCEPT BioRobotics-30.60% -23.73% -17.34% Stevanato Group 11.73%10.34%6.21% Which has better earnings & valuation, PRCT or STVN? Stevanato Group has higher revenue and earnings than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPROCEPT BioRobotics$224.50M9.80-$91.41M-$1.55-25.51Stevanato Group€1.19B6.89€127.45M€0.5450.37 Which has more risk & volatility, PRCT or STVN? PROCEPT BioRobotics has a beta of 1.03, indicating that its share price is 3% more volatile than the S&P 500. Comparatively, Stevanato Group has a beta of 0.55, indicating that its share price is 45% less volatile than the S&P 500. Do institutionals and insiders believe in PRCT or STVN? 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 17.4% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media favor PRCT or STVN? In the previous week, PROCEPT BioRobotics had 4 more articles in the media than Stevanato Group. MarketBeat recorded 7 mentions for PROCEPT BioRobotics and 3 mentions for Stevanato Group. Stevanato Group's average media sentiment score of 0.76 beat PROCEPT BioRobotics' score of 0.58 indicating that Stevanato Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PROCEPT BioRobotics 2 Very Positive mention(s) 3 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Stevanato Group 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate PRCT or STVN? PROCEPT BioRobotics presently has a consensus target price of $70.00, suggesting a potential upside of 77.05%. Given PROCEPT BioRobotics' higher probable upside, analysts plainly believe PROCEPT BioRobotics is more favorable than Stevanato Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PROCEPT BioRobotics 0 Sell rating(s) 2 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.78Stevanato Group 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 2.83 SummaryStevanato Group beats PROCEPT BioRobotics on 10 of the 17 factors compared between the two stocks. Get PROCEPT BioRobotics News Delivered to You Automatically Sign up to receive the latest news and ratings for PRCT and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding PRCT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PRCT vs. The Competition Export to ExcelMetricPROCEPT BioRoboticsMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.21B$6.73B$5.77B$10.50BDividend YieldN/A1.21%5.61%4.58%P/E Ratio-25.6226.6076.9527.03Price / Sales9.80197.43553.80128.22Price / CashN/A22.1425.8131.15Price / Book5.135.1213.886.54Net Income-$91.41M$178.07M$3.30B$271.76M7 Day Performance-0.09%2.81%2.46%3.85%1 Month Performance-4.11%7.82%4.90%8.34%1 Year Performance-50.72%21.96%83.63%27.26% PROCEPT BioRobotics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PRCTPROCEPT BioRobotics2.7792 of 5 stars$39.54+2.8%$70.00+77.1%-54.7%$2.21B$224.50M-25.62430Positive NewsSTVNStevanato GroupN/A€26.21-0.8%N/A+40.2%€7.94B€1.19B48.545,521Positive NewsIRTCiRhythm Technologies1.1583 of 5 stars$176.16-2.0%$163.82-7.0%+163.9%$5.78B$657.23M-60.122,000Positive NewsAnalyst ForecastBLCOBausch + Lomb1.8767 of 5 stars$15.23+0.2%$15.56+2.2%-23.5%$5.38B$4.79B-19.5213,500GKOSGlaukos4.7084 of 5 stars$80.72-2.5%$124.83+54.6%-33.7%$4.75B$383.48M-48.92780Positive NewsAnalyst ForecastTMDXTransMedics Group2.0774 of 5 stars$114.29-0.2%$122.11+6.8%-24.2%$3.91B$441.54M59.22210NVSTEnvista3.7742 of 5 stars$21.12+0.5%$20.92-0.9%+10.0%$3.49B$2.51B65.9912,300LIVNLivaNova2.7777 of 5 stars$55.43-1.4%$59.71+7.7%+8.6%$3.07B$1.25B-14.252,900Positive NewsSLNOSoleno Therapeutics4.4497 of 5 stars$51.17-4.6%$115.09+124.9%+9.6%$2.85BN/A-12.3630WRBYWarby Parker1.457 of 5 stars$26.37-1.4%$24.06-8.8%+100.2%$2.81B$771.32M-376.723,780INSPInspire Medical Systems4.8819 of 5 stars$80.90+1.1%$164.50+103.3%-62.9%$2.37B$802.80M46.761,246Analyst Downgrade Related Companies and Tools Related Companies STVN Competitors IRTC Competitors BLCO Competitors GKOS Competitors TMDX Competitors NVST Competitors LIVN Competitors SLNO Competitors WRBY Competitors INSP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PRCT) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PROCEPT BioRobotics Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share PROCEPT BioRobotics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PRCT Stock Alerts